Sep 13, 2016Mizuho Therapeutics ConferenceEvent: Mizuho Therapeutics ConferenceDate/Time: Wednesday, September 21, 2016Location: Langham Hotel, Boston, MA
Event: Mizuho Therapeutics ConferenceDate/Time: Wednesday, September 21, 2016Location: Langham Hotel, Boston, MA
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
Anavex Life Sciences Reports Fiscal 2024 Fourth Quarter Financial Results and Provides Business Update